Education
About Us
Working with TipRanks
Follow Us
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 213.24M | AU$ 231.93M | AU$ 14.55M | AU$ 3.20M | AU$ 717.00K |
| Gross Profit | AU$ 213.22M | AU$ 205.17M | AU$ 14.54M | AU$ 3.19M | AU$ 711.00K |
| Operating Income | AU$ 175.55M | AU$ 172.49M | AU$ -1.60M | AU$ -11.43M | AU$ -9.53M |
| EBITDA | AU$ 175.57M | AU$ 199.26M | AU$ -1.59M | AU$ -8.22M | AU$ -8.80M |
| Net Income | AU$ 142.04M | AU$ 157.08M | AU$ 184.00K | AU$ -7.79M | AU$ -9.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 222.24M | AU$ 228.54M | AU$ 40.18M | AU$ 36.78M | AU$ 24.19M |
| Total Assets | AU$ 409.71M | AU$ 247.97M | AU$ 43.27M | AU$ 40.06M | AU$ 24.95M |
| Total Debt | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 |
| Net Debt | AU$ -3.15M | AU$ -17.09M | AU$ -40.18M | AU$ -36.78M | AU$ -24.19M |
| Total Liabilities | AU$ 45.80M | AU$ 42.76M | AU$ 1.68M | AU$ 803.00K | AU$ 753.00K |
| Stockholders' Equity | AU$ 363.90M | AU$ 205.21M | AU$ 41.59M | AU$ 39.25M | AU$ 24.20M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -11.28M | AU$ 184.88M | AU$ 3.58M | AU$ -9.98M | AU$ -8.08M |
| Operating Cash Flow | AU$ -11.27M | AU$ 184.93M | AU$ 3.60M | AU$ -9.97M | AU$ -8.08M |
| Investing Cash Flow | AU$ 4.13M | AU$ -211.49M | AU$ -19.00K | AU$ -10.00K | AU$ -6.00K |
| Financing Cash Flow | AU$ -8.78M | AU$ 3.62M | AU$ -2.00K | AU$ 22.18M | AU$ 19.14M |